KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Restructuring Costs (2016 - 2025)

Teladoc Health's Restructuring Costs history spans 11 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Restructuring Costs rose 389.69% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $9.0 million, up 416.92%, while the annual FY2025 figure was $9.0 million, 416.92% up from the prior year.
  • Restructuring Costs for Q4 2025 was $2.2 million at Teladoc Health, up from $1.9 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $11.4 million in Q2 2021 and bottomed at $373000.0 in Q1 2024.
  • The 5-year median for Restructuring Costs is $3.6 million (2022), against an average of $3.7 million.
  • The largest annual shift saw Restructuring Costs soared 601.97% in 2021 before it crashed 93.72% in 2024.
  • A 5-year view of Restructuring Costs shows it stood at $4.6 million in 2021, then skyrocketed by 45.36% to $6.6 million in 2022, then crashed by 35.69% to $4.3 million in 2023, then crashed by 89.3% to $456000.0 in 2024, then soared by 389.69% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Restructuring Costs are $2.2 million (Q4 2025), $1.9 million (Q3 2025), and $2.7 million (Q2 2025).